Hosted on MSN49m
TD Cowen Initiates Coverage of KalVista Pharmaceuticals (KALV) with Buy RecommendationFintel reports that on January 7, 2025, TD Cowen initiated coverage of KalVista Pharmaceuticals (NasdaqGM:KALV) with a Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback